Published in Proc Natl Acad Sci U S A on September 30, 1997
Multifactor-dimensionality reduction reveals high-order interactions among estrogen-metabolism genes in sporadic breast cancer. Am J Hum Genet (2001) 17.43
Vascular actions of estrogens: functional implications. Pharmacol Rev (2008) 2.52
The role of estrogen in the initiation of breast cancer. J Steroid Biochem Mol Biol (2006) 1.94
Understanding the human health effects of chemical mixtures. Environ Health Perspect (2002) 1.83
Genetic polymorphisms in the catechol estrogen metabolism pathway and breast cancer risk. Cancer Epidemiol Biomarkers Prev (2009) 1.62
The molecular etiology of breast cancer: evidence from biomarkers of risk. Int J Cancer (2008) 1.62
Maternal dioxin exposure combined with a diet high in fat increases mammary cancer incidence in mice. Environ Health Perspect (2010) 1.60
Estrogen metabolism and risk of breast cancer in postmenopausal women. J Natl Cancer Inst (2012) 1.53
Association of CYP3A4 genotype with treatment-related leukemia. Proc Natl Acad Sci U S A (1998) 1.48
Quinol-based cyclic antioxidant mechanism in estrogen neuroprotection. Proc Natl Acad Sci U S A (2003) 1.37
High-resolution chromosome 3p allelotyping of breast carcinomas and precursor lesions demonstrates frequent loss of heterozygosity and a discontinuous pattern of allele loss. Am J Pathol (2001) 1.36
Major differences exist in the function and tissue-specific expression of human aflatoxin B1 aldehyde reductase and the principal human aldo-keto reductase AKR1 family members. Biochem J (1999) 1.26
Circulating 2-hydroxy- and 16alpha-hydroxy estrone levels and risk of breast cancer among postmenopausal women. Cancer Epidemiol Biomarkers Prev (2008) 1.22
Urine biomarkers of risk in the molecular etiology of breast cancer. Breast Cancer (Auckl) (2009) 1.21
Metformin represses self-renewal of the human breast carcinoma stem cells via inhibition of estrogen receptor-mediated OCT4 expression. PLoS One (2011) 1.19
Depurinating estrogen-DNA adducts in the etiology and prevention of breast and other human cancers. Future Oncol (2010) 1.18
Estrogen inhibits ATR signaling to cell cycle checkpoints and DNA repair. Mol Biol Cell (2009) 1.17
The involvement of DNA-damage and -repair defects in neurological dysfunction. Am J Hum Genet (2008) 1.17
A unified theory of carcinogenesis based on order-disorder transitions in DNA structure as studied in the human ovary and breast. Proc Natl Acad Sci U S A (1998) 1.16
Inhibition of estrogen signaling activates the NRF2 pathway in breast cancer. Breast Cancer Res Treat (2010) 1.14
Spectrum of HNF1A somatic mutations in hepatocellular adenoma differs from that in patients with MODY3 and suggests genotoxic damage. Diabetes (2010) 1.13
Estrogen-induced breast cancer: alterations in breast morphology and oxidative stress as a function of estrogen exposure. Toxicol Appl Pharmacol (2008) 1.12
Schistosome and liver fluke derived catechol-estrogens and helminth associated cancers. Front Genet (2014) 1.10
Pharmacogenomics: catechol O-methyltransferase to thiopurine S-methyltransferase. Cell Mol Neurobiol (2006) 1.09
Targeting cytochrome P450 enzymes: a new approach in anti-cancer drug development. Bioorg Med Chem (2007) 1.07
Redox cycling of catechol estrogens generating apurinic/apyrimidinic sites and 8-oxo-deoxyguanosine via reactive oxygen species differentiates equine and human estrogens. Chem Res Toxicol (2010) 1.07
Superoxide dismutase 3 is induced by antioxidants, inhibits oxidative DNA damage and is associated with inhibition of estrogen-induced breast cancer. Carcinogenesis (2012) 1.07
Perspectives on the chemical etiology of breast cancer. Environ Health Perspect (2002) 1.06
Detoxication of benzo[a]pyrene-7,8-dione by sulfotransferases (SULTs) in human lung cells. J Biol Chem (2012) 1.05
The discovery and mechanism of action of letrozole. Breast Cancer Res Treat (2007) 1.04
Why does infection with some helminths cause cancer? Trends Cancer (2015) 1.04
Circulating sex steroids and breast cancer risk in premenopausal women. Horm Cancer (2010) 1.03
Breast cancer risk reduction and membrane-bound catechol O-methyltransferase genetic polymorphisms. Cancer Res (2008) 1.02
Inhibition of catechol-O-methyltransferase increases estrogen-DNA adduct formation. Free Radic Biol Med (2007) 1.01
CYP1B1 expression in ovarian cancer in the laying hen Gallusdomesticus. Gynecol Oncol (2008) 1.01
Role of oestrogen receptors in bladder cancer development. Nat Rev Urol (2013) 1.00
Estrogen Receptor {alpha} Enhances the Rate of Oxidative DNA Damage by Targeting an Equine Estrogen Catechol Metabolite to the Nucleus. J Biol Chem (2009) 0.99
Semiquinone radical intermediate in catecholic estrogen-mediated cytotoxicity and mutagenesis: chemoprevention strategies with antioxidants. Proc Natl Acad Sci U S A (2003) 0.98
Mode of binding of the tuberculosis prodrug isoniazid to heme peroxidases: binding studies and crystal structure of bovine lactoperoxidase with isoniazid at 2.7 A resolution. J Biol Chem (2009) 0.98
Urinary estrogen metabolites and self-reported infertility in women infected with Schistosoma haematobium. PLoS One (2014) 0.97
Aberrant Keap1 methylation in breast cancer and association with clinicopathological features. Epigenetics (2012) 0.97
The molecular etiology and prevention of estrogen-initiated cancers: Ockham's Razor: Pluralitas non est ponenda sine necessitate. Plurality should not be posited without necessity. Mol Aspects Med (2013) 0.96
Polymorphisms in drug metabolism genes, smoking, and p53 mutations in breast cancer. Mol Carcinog (2008) 0.96
Mechanism of metabolic activation and DNA adduct formation by the human carcinogen diethylstilbestrol: the defining link to natural estrogens. Int J Cancer (2009) 0.95
A multigenic study on breast cancer risk associated with genetic polymorphisms of ER Alpha, COMT and CYP19 gene in BRCA1/BRCA2 negative Shanghai women with early onset breast cancer or affected relatives. J Cancer Res Clin Oncol (2007) 0.95
Induction of NAD(P)H-quinone oxidoreductase 1 by antioxidants in female ACI rats is associated with decrease in oxidative DNA damage and inhibition of estrogen-induced breast cancer. Carcinogenesis (2011) 0.95
Genetic polymorphisms in human SULT1A1 and UGT1A1 genes associate with breast tumor characteristics: a case-series study. Breast Cancer Res (2005) 0.94
Microsomal glutathione S-transferase gene polymorphisms and colorectal cancer risk in a Han Chinese population. Int J Colorectal Dis (2007) 0.94
Antioxidant butylated hydroxyanisole inhibits estrogen-induced breast carcinogenesis in female ACI rats. J Biochem Mol Toxicol (2009) 0.94
Antioxidant-mediated up-regulation of OGG1 via NRF2 induction is associated with inhibition of oxidative DNA damage in estrogen-induced breast cancer. BMC Cancer (2013) 0.93
Investigating the biochemical impact of DNA damage with structure-based probes: abasic sites, photodimers, alkylation adducts, and oxidative lesions. Biochemistry (2009) 0.93
Depurinating naphthalene-DNA adducts in mouse skin related to cancer initiation. Free Radic Biol Med (2009) 0.92
GSTP1 methylation and polymorphism increase the risk of breast cancer and the effects of diet and lifestyle in breast cancer patients. Exp Ther Med (2012) 0.92
Resveratrol and N-acetylcysteine block the cancer-initiating step in MCF-10F cells. Free Radic Biol Med (2010) 0.92
Resveratrol inhibits estrogen-induced breast carcinogenesis through induction of NRF2-mediated protective pathways. Carcinogenesis (2014) 0.91
Loss of miR-10a activates lpo and collaborates with activated Wnt signaling in inducing intestinal neoplasia in female mice. PLoS Genet (2013) 0.91
Urinary biomarkers suggest that estrogen-DNA adducts may play a role in the aetiology of non-Hodgkin lymphoma. Biomarkers (2009) 0.91
Estrogen metabolism and exposure in a genotypic-phenotypic model for breast cancer risk prediction. Cancer Epidemiol Biomarkers Prev (2011) 0.90
The Role of Human Aldo-Keto Reductases in the Metabolic Activation and Detoxication of Polycyclic Aromatic Hydrocarbons: Interconversion of PAH Catechols and PAH o-Quinones. Front Pharmacol (2012) 0.90
Estrogen metabolism and breast cancer. Cancer Lett (2014) 0.89
Identification of UDP-glucuronosyltransferase 1A10 in non-malignant and malignant human breast tissues. Steroids (2008) 0.89
The extrathyronine actions of iodine as antioxidant, apoptotic, and differentiation factor in various tissues. Thyroid (2013) 0.88
Serum estradiol levels associated with specific gene expression patterns in normal breast tissue and in breast carcinomas. BMC Cancer (2011) 0.88
Preferential induction of cytochrome P450 1A1 over cytochrome P450 1B1 in human breast epithelial cells following exposure to quercetin. J Steroid Biochem Mol Biol (2008) 0.88
Catechol-O-Methyltransferase (COMT) gene polymorphism and breast cancer risk in young women. Br J Cancer (2001) 0.88
Methoxychlor and estradiol induce oxidative stress DNA damage in the mouse ovarian surface epithelium. Toxicol Sci (2008) 0.88
Urinary polyphenols, glutathione S-transferases copy number variation, and breast cancer risk: results from the Shanghai women's health study. Mol Carcinog (2011) 0.88
Causes of genome instability: the effect of low dose chemical exposures in modern society. Carcinogenesis (2015) 0.86
Effect of tumour necrosis factor-alpha on estrogen metabolic pathways in breast cancer cells. J Cancer (2012) 0.86
Inhibition of catechol-Omicron-methyltransferase activity in human breast cancer cells enhances the biological effect of the green tea polyphenol (-)-EGCG. Oncol Rep (2010) 0.86
Selective estrogen receptor modulator delivery of quinone warheads to DNA triggering apoptosis in breast cancer cells. ACS Chem Biol (2009) 0.85
Reversal of Taxol resistance in hepatoma by cyclosporin A: involvement of the PI-3 kinase-AKT 1 pathway. Br J Cancer (2003) 0.85
Etoposide quinone is a redox-dependent topoisomerase II poison. Biochemistry (2011) 0.84
N-acetylcysteine blocks formation of cancer-initiating estrogen-DNA adducts in cells. Free Radic Biol Med (2010) 0.84
Cytochrome P450 1B1 Val432Leu polymorphism and breast cancer risk in Nigerian women: a case control study. Infect Agent Cancer (2009) 0.84
Environmental exposure to xenoestrogens and oestrogen related cancers: reproductive system, breast, lung, kidney, pancreas, and brain. Environ Health (2012) 0.84
Structural evidence for the order of preference of inorganic substrates in mammalian heme peroxidases: crystal structure of the complex of lactoperoxidase with four inorganic substrates, SCN, I, Br and Cl. Int J Biochem Mol Biol (2011) 0.84
NAD(P)H:quinone oxidoreductase 1 Arg139Trp and Pro187Ser polymorphisms imbalance estrogen metabolism towards DNA adduct formation in human mammary epithelial cells. J Steroid Biochem Mol Biol (2009) 0.83
Efficient synthesis, liquid chromatography purification, and tandem mass spectrometric characterization of estrogen-modified DNA bases. Chem Res Toxicol (2008) 0.83
The etiology and prevention of breast cancer. Drug Discov Today Dis Mech (2012) 0.83
Hormone-related pathways and risk of breast cancer subtypes in African American women. Breast Cancer Res Treat (2015) 0.83
Proton linkage for CO binding and redox properties of bovine lactoperoxidase. Biophys J (2004) 0.83
Dietary γ-Tocopherol-Rich Mixture Inhibits Estrogen-Induced Mammary Tumorigenesis by Modulating Estrogen Metabolism, Antioxidant Response, and PPARγ. Cancer Prev Res (Phila) (2015) 0.83
Endogenous hormones and the aetiology of breast cancer. Breast Cancer Res (1999) 0.82
Estrogen exposure, metabolism, and enzyme variants in a model for breast cancer risk prediction. Cancer Inform (2009) 0.82
Nuclear localization of catechol-O-methyltransferase in neoplastic and nonneoplastic mammary epithelial cells. Am J Pathol (2000) 0.82
Formation of two novel estrogen guanine adducts and HPLC/MS detection of 4-hydroxyestradiol-N7-guanine in human urine. Chem Res Toxicol (2008) 0.82
Src supports UDP-glucuronosyltransferase-2B7 detoxification of catechol estrogens associated with breast cancer. Biochem Biophys Res Commun (2009) 0.81
Improved profiling of estrogen metabolites by orbitrap LC/MS. Steroids (2014) 0.81
Identifying the Tautomeric Form of a Deoxyguanosine-Estrogen Quinone Intermediate. Metabolites (2015) 0.81
Benzene and dopamine catechol quinones could initiate cancer or neurogenic disease. Free Radic Biol Med (2009) 0.81
Tocopherols inhibit oxidative and nitrosative stress in estrogen-induced early mammary hyperplasia in ACI rats. Mol Carcinog (2014) 0.81
Estrogen carcinogenesis: specific identification of estrogen-modified nucleobase in breast tissue from women. Chem Res Toxicol (2008) 0.81
Epimerization of green tea catechins during brewing does not affect the ability to poison human type II topoisomerases. Chem Res Toxicol (2013) 0.80
Estradiol uptake, toxicity, metabolism, and adverse effects on cadmium-treated amphibian embryos. Environ Health Perspect (2004) 0.80
Intestinal cytochromes P450 regulating the intestinal microbiota and its probiotic profile. Microb Ecol Health Dis (2012) 0.80
Comparison of estrogen-derived ortho-quinone and para-quinol concerning induction of oxidative stress. J Steroid Biochem Mol Biol (2007) 0.80
Differential Effects of Glycyrrhiza Species on Genotoxic Estrogen Metabolism: Licochalcone A Downregulates P450 1B1, whereas Isoliquiritigenin Stimulates It. Chem Res Toxicol (2015) 0.80
Depurinating estrogen-DNA adducts, generators of cancer initiation: their minimization leads to cancer prevention. Clin Transl Med (2016) 0.79
Adenocarcinoma of the vagina. Association of maternal stilbestrol therapy with tumor appearance in young women. N Engl J Med (1971) 11.95
Carcinogenesis by chemicals: an overview--G. H. A. Clowes memorial lecture. Cancer Res (1970) 4.83
Increased cell division as a cause of human cancer. Cancer Res (1990) 3.38
Molecular mechanisms of estrogen carcinogenesis. Annu Rev Pharmacol Toxicol (1996) 2.91
Searches for ultimate chemical carcinogens and their reactions with cellular macromolecules. Cancer (1981) 2.65
17 beta-estradiol hydroxylation catalyzed by human cytochrome P450 1B1. Proc Natl Acad Sci U S A (1996) 2.22
Hormones and mammary carcinogenesis in mice, rats, and humans: a unifying hypothesis. Proc Natl Acad Sci U S A (1995) 2.09
Carcinogenicity of catechol estrogens in Syrian hamsters. J Steroid Biochem (1986) 1.82
Growth factor synthesis and human breast cancer progression. J Natl Cancer Inst (1995) 1.68
The etiology of breast cancer. Characteristic alteration in hydroxyl radical-induced DNA base lesions during oncogenesis with potential for evaluating incidence risk. Cancer (1993) 1.63
P450 enzymes of estrogen metabolism. Pharmacol Ther (1993) 1.61
How cancer arises. Sci Am (1996) 1.58
Molecular characteristics of catechol estrogen quinones in reactions with deoxyribonucleosides. Chem Res Toxicol (1996) 1.57
Estrogen carcinogenesis in Syrian hamster tissues: role of metabolism. Fed Proc (1987) 1.56
4-Hydroxylation of estrogens as marker of human mammary tumors. Proc Natl Acad Sci U S A (1996) 1.55
Mouse cytochrome P-450EF, representative of a new 1B subfamily of cytochrome P-450s. Cloning, sequence determination, and tissue expression. J Biol Chem (1994) 1.36
The effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on estrogen metabolism in MCF-7 breast cancer cells: evidence for induction of a novel 17 beta-estradiol 4-hydroxylase. J Steroid Biochem Mol Biol (1994) 1.36
Relating aromatic hydrocarbon-induced DNA adducts and c-H-ras mutations in mouse skin papillomas: the role of apurinic sites. Proc Natl Acad Sci U S A (1995) 1.35
Free radical generation by redox cycling of estrogens. Free Radic Biol Med (1990) 1.29
Catecholoestrogens (2-and 4-hydroxyoestrogens): chemistry, biogenesis, metabolism, occurrence and physiological significance. Acta Endocrinol Suppl (Copenh) (1980) 1.22
Models of DNA structure achieve almost perfect discrimination between normal prostate, benign prostatic hyperplasia (BPH), and adenocarcinoma and have a high potential for predicting BPH and prostate cancer. Proc Natl Acad Sci U S A (1997) 1.18
8-Hydroxylation of guanine bases in kidney and liver DNA of hamsters treated with estradiol: role of free radicals in estrogen-induced carcinogenesis. Cancer Res (1994) 1.17
4-Hydroxylation of estradiol by human uterine myometrium and myoma microsomes: implications for the mechanism of uterine tumorigenesis. Proc Natl Acad Sci U S A (1995) 1.15
Synthesis and characterization of estrogen 2,3- and 3,4-quinones. Comparison of DNA adducts formed by the quinones versus horseradish peroxidase-activated catechol estrogens. Chem Res Toxicol (1993) 1.14
Estrogen-induced tumors of the kidney. III. Growth characteristics in the Syrian hamster. Natl Cancer Inst Monogr (1959) 1.09
Cytochrome P-450-mediated redox cycling of estrogens. J Biol Chem (1986) 1.09
The approach to understanding aromatic hydrocarbon carcinogenesis. The central role of radical cations in metabolic activation. Pharmacol Ther (1992) 1.08
Elevated 4-hydroxylation of estradiol by hamster kidney microsomes: a potential pathway of metabolic activation of estrogens. Endocrinology (1992) 1.05
Induction by estrogens of lipid peroxidation and lipid peroxide-derived malonaldehyde-DNA adducts in male Syrian hamsters: role of lipid peroxidation in estrogen-induced kidney carcinogenesis. Carcinogenesis (1995) 1.02
Relative carcinogenic activity of various synthetic and natural estrogens in the Syrian hamster kidney. Cancer Res (1983) 1.02
An o-quinone form of estrogen produces free radicals in human breast cancer cells: correlation with DNA damage. Chem Res Toxicol (1994) 1.02
Identification of microsomal, organic hydroperoxide-dependent catechol estrogen formation: comparison with NADPH-dependent mechanism. Pharmacology (1988) 0.93
Conversion of estrone to 2- and 4-hydroxyestrone by hamster kidney and liver microsomes: implications for the mechanism of estrogen-induced carcinogenesis. Endocrinology (1994) 0.93
Rat CYP1B1: an adrenal cytochrome P450 that exhibits sex-dependent expression in livers and kidneys of TCDD-treated animals. Carcinogenesis (1995) 0.91
Characterization of the nontransformed and transformed androgen receptor and heat shock protein 90 with high-performance hydrophobic-interaction chromatography. J Steroid Biochem (1988) 0.91
32P-postlabeling analysis of benzo[a]pyrene-DNA adducts formed in vitro and in vivo. Chem Res Toxicol (1992) 0.87
Gas chromatography/mass spectrometry of catechol estrogens. Steroids (1992) 0.87
Carcinogenicity and metabolic activation of hexestrol. Chem Biol Interact (1985) 0.86
Oxidative metabolism of the synthetic estrogens hexestrol and dienestrol indicates reactive intermediates. Adv Exp Med Biol (1981) 0.86
Dependence of benzo[a]pyrene metabolic profile on the concentration of cumene hydroperoxide with uninduced and induced rat liver microsomes. Biochem Pharmacol (1986) 0.81
Outcomes after laparoscopic Roux-en-Y gastric bypass for morbid obesity. Ann Surg (2000) 4.05
Laparoscopic sleeve gastrectomy as an initial weight-loss procedure for high-risk patients with morbid obesity. Surg Endosc (2006) 2.51
Space charge effects in Fourier transform mass spectrometry. Mass calibration. Anal Chem (1984) 2.12
Overview of research on women in medicine--issues for public policymakers. Public Health Rep (1986) 1.90
Biochemical studies of the excitable membrane of Paramecium tetraurelia. III. Proteins of cilia and ciliary membranes. J Cell Biol (1980) 1.78
Evaluation of four modalities of periodontal therapy. Mean probing depth, probing attachment level and recession changes. J Periodontol (1988) 1.77
Genotoxic metabolites of estradiol in breast: potential mechanism of estradiol induced carcinogenesis. J Steroid Biochem Mol Biol (2003) 1.66
Central role of radical cations in metabolic activation of polycyclic aromatic hydrocarbons. Xenobiotica (1995) 1.65
Evidence that a burst of DNA depurination in SENCAR mouse skin induces error-prone repair and forms mutations in the H-ras gene. Oncogene (2001) 1.65
Identification of the V factor needed for synthesis of the iron-molybdenum cofactor of nitrogenase as homocitrate. Nature (1987) 1.64
Bladder carcinoma with lymphoepithelioma-like differentiation: a report of 9 cases. J Urol (1998) 1.60
The importance of the depth of invasion in stage T1 bladder carcinoma: a prospective cohort study. J Urol (1997) 1.59
Molecular characteristics of catechol estrogen quinones in reactions with deoxyribonucleosides. Chem Res Toxicol (1996) 1.57
Systemic to pulmonary collaterals in very low birth weight infants: color doppler detection of systemic to pulmonary connections during neonatal and early infancy period. Pediatrics (2000) 1.55
A review of longitudinal studies that compared periodontal therapies. J Periodontol (1993) 1.52
Oral histoplasmosis in a patient infected with HIV. A case report. Oral Surg Oral Med Oral Pathol (1994) 1.49
The smoking cessation efficacy of varying doses of nicotine patch delivery systems 4 to 5 years post-quit day. Prev Med (1999) 1.42
Ovary-intact, but not ovariectomized female ACI rats treated with 17beta-estradiol rapidly develop mammary carcinoma. Carcinogenesis (1997) 1.41
Long-term followup of a bladder carcinoma cohort: questionable value of radical radiotherapy. J Urol (1997) 1.39
Change in prevalence and antibiotic resistance of Enterococcus species isolated from blood cultures over an 8-year period. Antimicrob Agents Chemother (1997) 1.37
Comparative dose-response tumorigenicity studies of dibenzo[alpha,l]pyrene versus 7,12-dimethylbenz[alpha]anthracene, benzo[alpha]pyrene and two dibenzo[alpha,l]pyrene dihydrodiols in mouse skin and rat mammary gland. Carcinogenesis (1991) 1.37
Relating aromatic hydrocarbon-induced DNA adducts and c-H-ras mutations in mouse skin papillomas: the role of apurinic sites. Proc Natl Acad Sci U S A (1995) 1.35
Primary small cell carcinoma of the bladder: a report of 25 cases. J Urol (1995) 1.33
Isolation and structure of the cell growth inhibitory constituents from the western Pacific marine sponge Axinella sp. J Med Chem (1991) 1.32
The treatment of inflammatory polyneuropathy by plasma exchange. J Neurol Neurosurg Psychiatry (1982) 1.31
Longitudinal alveolar bone loss in postmenopausal osteoporotic/osteopenic women. Osteoporos Int (1999) 1.30
Pulse oximetry for continuous oxygen monitoring in sick newborn infants. J Pediatr (1986) 1.29
Fourier transform mass spectrometry. Science (1984) 1.29
Clinical spectrum of fungal infections after orthotopic liver transplantation. Arch Surg (1991) 1.27
Imbalance of estrogen homeostasis in kidney and liver of hamsters treated with estradiol: implications for estrogen-induced initiation of renal tumors. Chem Res Toxicol (2001) 1.26
Recurrence and progression in low grade papillary urothelial tumors. J Urol (1999) 1.25
Tumor-initiating activity and carcinogenicity of dibenzo[a,l]pyrene versus 7,12-dimethylbenz[a]anthracene and benzo[a]pyrene at low doses in mouse skin. Carcinogenesis (1993) 1.24
Translocation t(1;3)(p36.3;q25) is a nonrandom aberration in epithelioid hemangioendothelioma. Am J Surg Pathol (2001) 1.24
Improved quantitation of minimal residual disease in multiple myeloma using real-time polymerase chain reaction and plasmid-DNA complementarity determining region III standards. Cancer Res (1998) 1.23
Regulation of 'malic' enzyme of Solanum tuberosum by metabolites. Biochem J (1974) 1.22
Overexpression of macrophage inhibitory cytokine-1 induces metastasis of human prostate cancer cells through the FAK-RhoA signaling pathway. Oncogene (2009) 1.19
Maximum oxygen consumption and the ADAPT quality-of-life scale. Arch Phys Med Rehabil (1982) 1.18
Amino-terminal trimming of peptides for presentation on major histocompatibility complex class II molecules. Proc Natl Acad Sci U S A (1997) 1.17
Blood cultures in neonates with percutaneous central venous catheters. Arch Dis Child (1987) 1.17
Role of human cytochrome P450 1A1, 1A2, 1B1, and 3A4 in the 2-, 4-, and 16alpha-hydroxylation of 17beta-estradiol. Metabolism (2001) 1.17
Applications and mechanisms of charge-remote fragmentation. Mass Spectrom Rev (2001) 1.17
Bioactive transforming growth factor-beta in the lungs of extremely low birthweight neonates predicts the need for home oxygen supplementation. Biol Neonate (2000) 1.16
The effect of feedback in learning clinical diagnosis. J Med Educ (1986) 1.16
Diagnostic value of cytology of voided urine. Acta Cytol (1985) 1.15
Fast atom bombardment and tandem mass spectrometry of phosphatidylserine and phosphatidylcholine. Lipids (1986) 1.15
Ionic liquids as matrixes for matrix-assisted laser desorption/ionization mass spectrometry. Anal Chem (2001) 1.15
Influence of estrogen and osteopenia/osteoporosis on clinical periodontitis in postmenopausal women. J Periodontol (1999) 1.14
Stage progression in Ta papillary urothelial tumors: relationship to grade, immunohistochemical expression of tumor markers, mitotic frequency and DNA ploidy. J Urol (2001) 1.13
The relationships among tumor-infiltrating lymphocytes, histopathologic findings, and long-term clinical follow-up in renal cell carcinoma. Mod Pathol (1992) 1.13
Total indoor smoking ban and smoker behavior. Prev Med (1992) 1.12
Long-term evaluation of periodontal therapy: I. Response to 4 therapeutic modalities. J Periodontol (1996) 1.12
A randomized trial of nasopharyngeal-synchronized intermittent mandatory ventilation versus nasopharyngeal continuous positive airway pressure in very low birth weight infants after extubation. J Perinatol (1999) 1.11
Fast atom bombardment combined with tandem mass spectrometry for the determination of cyclic peptides. Anal Chem (1984) 1.10
Complete structural elucidation of triacylglycerols by tandem sector mass spectrometry. Anal Chem (1998) 1.10
The seasonal risk of pediatric/juvenile acute lymphocytic leukemia in the United States. J Chronic Dis (1987) 1.10
Synthesis and structure elucidation of estrogen quinones conjugated with cysteine, N-acetylcysteine, and glutathione. Chem Res Toxicol (1998) 1.10
Pulse oximetry in very low birth weight infants with acute and chronic lung disease. Pediatrics (1987) 1.10
Effects of low dose sympathetic inhibition on glomerulosclerosis and albuminuria in subtotally nephrectomized rats. J Am Soc Nephrol (2000) 1.09
The approach to understanding aromatic hydrocarbon carcinogenesis. The central role of radical cations in metabolic activation. Pharmacol Ther (1992) 1.08
Potential biomarker for early risk assessment of prostate cancer. Prostate (2006) 1.08
Long-term followup of all patients with muscle invasive (stages T2, T3 and T4) bladder carcinoma in a geographical region. J Urol (1997) 1.08
The effect of smoking on the response to periodontal therapy. J Clin Periodontol (1994) 1.07
The characterization, molecular cloning, and expression of a novel hematopoietic cell antigen from CD34+ human bone marrow cells. Blood (1997) 1.07
Primary adenocarcinoma of the urinary bladder. A clinicopathologic and prognostic study. Cancer (1983) 1.06
Primary signet ring cell carcinoma of the bladder: a report on 10 cases. Scand J Urol Nephrol (1997) 1.06
Identification and quantitation of benzo[a]pyrene-DNA adducts formed in mouse skin. Chem Res Toxicol (1993) 1.06
Decreased expression of cellular prostatic acid phosphatase increases tumorigenicity of human prostate cancer cells. J Urol (2001) 1.06
Nonrandom nature of in vivo methylation of dimethylnitrosamine and the subsequent removal of methylated products from rat liver chromatin DNA. Cancer Res (1976) 1.06
Expression of interleukin-8 in primary and metastatic malignant melanoma of the skin. Melanoma Res (1999) 1.06
The nested variant of transitional cell carcinoma--a rare neoplasm with poor prognosis. Scand J Urol Nephrol (2001) 1.06
Overexpression of GalNAc-transferase GalNAc-T3 promotes pancreatic cancer cell growth. Oncogene (2011) 1.05
FAB MS/MS for phosphatidylinositol, -glycerol, -ethanolamine and other complex phospholipids. Lipids (1987) 1.05
Prospective evaluation of percutaneous central venous silastic catheters in newborn infants with birth weights of 510 to 3,920 grams. Pediatrics (1986) 1.05
Chronic interstitial cystitis: a heterogeneous syndrome. J Urol (1987) 1.04
Antineoplastic agents. 278. Isolation and structure of axinastatins 2 and 3 from a western Caroline Island marine sponge. J Med Chem (1994) 1.03
Gas-phase stability of double-stranded oligodeoxynucleotides and their noncovalent complexes with DNA-binding drugs as revealed by collisional activation in an ion trap. J Am Soc Mass Spectrom (2000) 1.03
Initiation of cancer and other diseases by catechol ortho-quinones: a unifying mechanism. Cell Mol Life Sci (2002) 1.03
Special characteristics of atherosclerosis in chronic renal failure. Clin Nephrol (2003) 1.03
Electrospray ionization mass spectrometry and hydrogen/deuterium exchange for probing the interaction of calmodulin with calcium. J Am Soc Mass Spectrom (1999) 1.02
Levels of cigarette consumption and response to periodontal therapy. J Periodontol (1996) 1.02
The treatment of chronic relapsing and chronic progressive idiopathic inflammatory polyneuropathy by plasma exchange. J Neurol Sci (1981) 1.01
Spectral characterization of catechol estrogen quinone (CEQ)-derived DNA adducts and their identification in human breast tissue extract. Chem Res Toxicol (2003) 1.01
A new transformation-deficient mutant of Haemophilus influenzae Rd with normal DNA uptake. J Bacteriol (1998) 1.00
Characterization and purification of a soluble protein controlling Ca-channel activity in paramecium. Cell (1984) 1.00
Matrix-assisted laser desorption/ionization mass spectrometry methods for oligodeoxynucleotides: improvements in matrix, detection limits, quantification, and sequencing. J Am Soc Mass Spectrom (2000) 1.00